{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:53:34Z","timestamp":1793933614839,"version":"4.8.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the NATCM\u2019s Project for High-level Construction of Key TCM Disciplines in Minority Pharmacy","award":["zyyzdxk-2023165"],"award-info":[{"award-number":["zyyzdxk-2023165"]}]},{"name":"the Guangxi Natural Science Foundation","award":["2023GXNSFBA026188"],"award-info":[{"award-number":["2023GXNSFBA026188"]}]},{"name":"the Guangxi Key Discipline of TCM","award":["GZXK-Z-20-60"],"award-info":[{"award-number":["GZXK-Z-20-60"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03998-6","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T10:02:39Z","timestamp":1747994559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Aggregate index of systemic inflammation tied to increased fatty liver disease risk: insights from NHANES data"],"prefix":"10.1186","volume":"25","author":[{"given":"Meng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingli","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zujie","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"3998_CR1","doi-asserted-by":"publisher","first-page":"goae069","DOI":"10.1093\/gastro\/goae069","volume":"12","author":"R Manikat","year":"2024","unstructured":"Manikat R, Ahmed A, Kim D. Current epidemiology of chronic liver disease. Gastroenterol Rep (Oxf). 2024;12:goae069.","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"1","key":"3998_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology"},{"key":"3998_CR3","doi-asserted-by":"publisher","first-page":"204201882412743","DOI":"10.1177\/20420188241274350","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Bu Y, Zhao R, Han C. Metabolic-associated fatty liver disease and pregnancy complications: new challenges and clinical perspectives. Ther Adv Endocrinol Metab. 2024;15:20420188241274350.","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"8","key":"3998_CR4","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.3390\/nu15081857","volume":"15","author":"Q Zhao","year":"2023","unstructured":"Zhao Q, Tan X, Su Z, Manzi HP, Su L, Tang Z, Zhang Y. The relationship between the dietary inflammatory index (DII) and metabolic syndrome (MetS) in middle-aged and elderly individuals in the united States. Nutrients. 2023;15(8):1857.","journal-title":"Nutrients"},{"key":"3998_CR5","doi-asserted-by":"publisher","first-page":"1380476","DOI":"10.3389\/fimmu.2024.1380476","volume":"15","author":"J Kopczy\u0144ska","year":"2024","unstructured":"Kopczy\u0144ska J, Kowalczyk M. The potential of short-chain fatty acid epigenetic regulation in chronic low-grade inflammation and obesity. Front Immunol. 2024;15:1380476.","journal-title":"Front Immunol"},{"key":"3998_CR6","doi-asserted-by":"publisher","first-page":"977485","DOI":"10.3389\/fimmu.2022.977485","volume":"13","author":"J Yao","year":"2022","unstructured":"Yao J, Wu D, Qiu Y. Adipose tissue macrophage in obesity-associated metabolic diseases. Front Immunol. 2022;13:977485.","journal-title":"Front Immunol"},{"issue":"11","key":"3998_CR7","doi-asserted-by":"publisher","first-page":"9677","DOI":"10.3390\/ijms24119677","volume":"24","author":"R Frankowski","year":"2023","unstructured":"Frankowski R, Kobierecki M, Wittczak A, R\u00f3\u017cycka-Kosmalska M, Pietras T, Sipowicz K, Kosmalski M. Type 2 diabetes mellitus, non-alcoholic fatty liver disease, and metabolic repercussions: the vicious cycle and its interplay with inflammation. Int J Mol Sci. 2023;24(11):9677.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3998_CR8","doi-asserted-by":"publisher","first-page":"e1840","DOI":"10.1002\/wrna.1840","volume":"15","author":"O Adesanya","year":"2024","unstructured":"Adesanya O, Das D, Kalsotra A. Emerging roles of RNA-binding proteins in fatty liver disease. Wiley Interdiscip Rev RNA. 2024;15(2):e1840.","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"3","key":"3998_CR9","doi-asserted-by":"publisher","first-page":"101847","DOI":"10.1016\/j.clinre.2021.101847","volume":"46","author":"J Tang","year":"2022","unstructured":"Tang J, Chen C, Zhou M, Wang J, Feng Z, Wang M. NLR contributed to the diagnosis and detection of nonalcoholic fatty liver disease: A meta-analysis. Clin Res Hepatol Gastroenterol. 2022;46(3):101847.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"3998_CR10","doi-asserted-by":"publisher","first-page":"1337241","DOI":"10.3389\/fimmu.2024.1337241","volume":"15","author":"K Liu","year":"2024","unstructured":"Liu K, Tang S, Liu C, Ma J, Cao X, Yang X, Zhu Y, Chen K, Liu Y, Zhang C, et al. Systemic immune-inflammatory biomarkers (SII, NLR, PLR and LMR) linked to non-alcoholic fatty liver disease risk. Front Immunol. 2024;15:1337241.","journal-title":"Front Immunol"},{"issue":"1","key":"3998_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10238-024-01539-1","volume":"25","author":"Y Yang","year":"2025","unstructured":"Yang Y, He X, Tan S, Qu X, Huang W, Cai J, You J, Fu X, He Y, Yang H. The association between Immunoinflammatory biomarkers NLR, PLR, LMR and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Clin Exp Med. 2025;25(1):39.","journal-title":"Clin Exp Med"},{"issue":"1","key":"3998_CR12","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1186\/s12872-023-03661-6","volume":"23","author":"N Jin","year":"2023","unstructured":"Jin N, Huang L, Hong J, Zhao X, Hu J, Wang S, Chen X, Rong J, Lu Y. The association between systemic inflammation markers and the prevalence of hypertension. BMC Cardiovasc Disord. 2023;23(1):615.","journal-title":"BMC Cardiovasc Disord"},{"key":"3998_CR13","doi-asserted-by":"publisher","first-page":"111575","DOI":"10.1016\/j.diabres.2024.111575","volume":"209","author":"J Zhang","year":"2024","unstructured":"Zhang J, Fan X, Xu Y, Wang K, Xu T, Han T, Hu C, Li R, Lin X, Jin L. Association between inflammatory biomarkers and mortality in individuals with type 2 diabetes: NHANES 2005\u20132018. Diabetes Res Clin Pract. 2024;209:111575.","journal-title":"Diabetes Res Clin Pract"},{"key":"3998_CR14","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.2147\/JIR.S503648","volume":"18","author":"D Shen","year":"2025","unstructured":"Shen D, Cai X, Hu J, Song S, Zhu Q, Ma H, Zhang Y, Ma R, Zhou P, Yang W, et al. Inflammatory indices and MAFLD prevalence in hypertensive patients: a large-scale cross-sectional analysis from China. J Inflamm Res. 2025;18:1623\u201338.","journal-title":"J Inflamm Res"},{"issue":"1","key":"3998_CR15","doi-asserted-by":"publisher","first-page":"17009","DOI":"10.1289\/EHP12188","volume":"132","author":"Z Stanfield","year":"2024","unstructured":"Stanfield Z, Setzer RW, Hull V, Sayre RR, Isaacs KK, Wambaugh JF. Characterizing chemical exposure trends from NHANES urinary biomonitoring data. Environ Health Perspect. 2024;132(1):17009.","journal-title":"Environ Health Perspect"},{"issue":"5","key":"3998_CR16","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","volume":"66","author":"T Karlas","year":"2017","unstructured":"Karlas T, Petroff D, Sasso M, Fan JG, Mi YQ, de L\u00e9dinghen V, Kumar M, Lupsor-Platon M, Han KH, Cardoso AC, et al. Individual patient data meta-analysis of controlled Attenuation parameter (CAP) technology for assessing steatosis. J Hepatol. 2017;66(5):1022\u201330.","journal-title":"J Hepatol"},{"issue":"7","key":"3998_CR17","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1080\/00365521.2022.2041085","volume":"57","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Li H. Association of serum vitamin C with liver fibrosis in adults with nonalcoholic fatty liver disease. Scand J Gastroenterol. 2022;57(7):872\u201377.","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"3998_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.21037\/hbsn-23-556","volume":"13","author":"TW Lou","year":"2024","unstructured":"Lou TW, Yang RX, Fan JG. The global burden of fatty liver disease: the major impact of China. Hepatobiliary Surg Nutr. 2024;13(1):119\u201323.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"4","key":"3998_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4254\/wjh.v12.i4.149","volume":"12","author":"L Lind","year":"2020","unstructured":"Lind L, Johansson L, Ahlstr\u00f6m H, Eriksson JW, Larsson A, Ris\u00e9rus U, Kullberg J, Oscarsson J. Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population. World J Hepatol. 2020;12(4):149\u201359.","journal-title":"World J Hepatol"},{"issue":"1","key":"3998_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12944-023-01808-0","volume":"22","author":"H Peng","year":"2023","unstructured":"Peng H, Zhang J, Huang X, Xu M, Huang J, Wu Y, Peng XE. Development and validation of an online dynamic nomogram based on the atherogenic index of plasma to screen nonalcoholic fatty liver disease. Lipids Health Dis. 2023;22(1):44.","journal-title":"Lipids Health Dis"},{"issue":"2","key":"3998_CR21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1089\/dia.2011.0213","volume":"14","author":"G Kuppan","year":"2012","unstructured":"Kuppan G, Anjana RM, Deepa M, Paramasivam P, Chandrakumar S, Kaliyaperumal V, Mohan V. Inflammatory markers in relation to nonalcoholic fatty liver disease in urban South Indians. Diabetes Technol Ther. 2012;14(2):152\u201358.","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"3998_CR22","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1309\/6VJ4DWGYDU0XYJ8Q","volume":"127","author":"M Manco","year":"2007","unstructured":"Manco M, Marcellini M, Giannone G, Nobili V. Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease. Am J Clin Pathol. 2007;127(6):954\u201360.","journal-title":"Am J Clin Pathol"},{"key":"3998_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-230X-9-16","volume":"9","author":"N Oruc","year":"2009","unstructured":"Oruc N, Ozutemiz O, Yuce G, Akarca US, Ersoz G, Gunsar F, Batur Y. Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease: a case control study. BMC Gastroenterol. 2009;9:16.","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"3998_CR24","first-page":"1134","volume":"48","author":"MN Ren","year":"2024","unstructured":"Ren MN, Deng KT. Value of combined serum test indices and CRP in the diagnosis of nonalcoholic fatty liver disease. Guizhou Med J. 2024;48(7):1134\u201336.","journal-title":"Guizhou Med J"},{"issue":"23","key":"3998_CR25","doi-asserted-by":"publisher","first-page":"16898","DOI":"10.3390\/ijms242316898","volume":"24","author":"OM Tiuc\u0103","year":"2023","unstructured":"Tiuc\u0103 OM, Morariu SH, Mariean CR, Tiuc\u0103 RA, Nicolescu AC, Cotoi OS. Predictive performances of blood-count-derived inflammatory markers for liver fibrosis severity in psoriasis vulgaris. Int J Mol Sci. 2023;24(23):16898.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3998_CR26","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/hep.30626","volume":"70","author":"A Lonardo","year":"2019","unstructured":"Lonardo A, Nascimbeni F, Ballestri S, Fairweather D, Win S, Than TA, Abdelmalek MF, Suzuki A. Sex differences in nonalcoholic fatty liver disease: state of the Art and identification of research gaps. Hepatology. 2019;70(4):1457\u201369.","journal-title":"Hepatology"},{"issue":"9","key":"3998_CR27","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1007\/s10620-023-07987-1","volume":"68","author":"BB McNally","year":"2023","unstructured":"McNally BB, Rangan P, Wijarnpreecha K, Fallon MB. Fibrosis-4 index score predicts concomitant coronary artery diseases across the spectrum of fatty liver disease. Dig Dis Sci. 2023;68(9):3765\u201373.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"3998_CR28","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s10620-021-06953-z","volume":"67","author":"S Nobarani","year":"2022","unstructured":"Nobarani S, Alaei-Shahmiri F, Aghili R, Malek M, Poustchi H, Lahouti M, Khamseh ME. Visceral adipose tissue and non-alcoholic fatty liver disease in patients with type 2 diabetes. Dig Dis Sci. 2022;67(4):1389\u201398.","journal-title":"Dig Dis Sci"},{"issue":"6","key":"3998_CR29","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1002\/hep4.1896","volume":"6","author":"DO Garcia","year":"2022","unstructured":"Garcia DO, Morrill KE, Lopez-Pentecost M, Villavicencio EA, Vogel RM, Bell ML, Klimentidis YC, Marrero DG, Thomson CA. Nonalcoholic fatty liver disease and associated risk factors in a community-based sample of Mexican-origin adults. Hepatol Commun. 2022;6(6):1322\u201335.","journal-title":"Hepatol Commun"},{"issue":"9","key":"3998_CR30","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.3390\/jcm10092040","volume":"10","author":"CM Perdomo","year":"2021","unstructured":"Perdomo CM, Garcia-Fernandez N, Escalada J. Diabetic kidney disease, cardiovascular disease and non-alcoholic fatty liver disease: a new triumvirate. J Clin Med. 2021;10(9):2040.","journal-title":"J Clin Med"},{"key":"3998_CR31","doi-asserted-by":"publisher","first-page":"111229","DOI":"10.1016\/j.cellsig.2024.111229","volume":"120","author":"K Yan","year":"2024","unstructured":"Yan K. Recent advances in the effect of adipose tissue inflammation on insulin resistance. Cell Signal. 2024;120:111229.","journal-title":"Cell Signal"},{"issue":"20","key":"3998_CR32","doi-asserted-by":"publisher","first-page":"15489","DOI":"10.3390\/ijms242015489","volume":"24","author":"YE Cho","year":"2023","unstructured":"Cho YE, Kim Y, Kim SJ, Lee H, Hwang S. Overexpression of interleukin-8 promotes the progression of fatty liver to nonalcoholic steatohepatitis in mice. Int J Mol Sci. 2023;24(20):15489.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3998_CR33","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41419-020-2582-1","volume":"11","author":"X Zhao","year":"2020","unstructured":"Zhao X, Yang L, Chang N, Hou L, Zhou X, Yang L, Li L. Neutrophils undergo switch of apoptosis to NETosis during murine fatty liver injury via S1P receptor 2 signaling. Cell Death Dis. 2020;11(5):379.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3998_CR34","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1038\/s41598-021-84674-z","volume":"11","author":"V Cairoli","year":"2021","unstructured":"Cairoli V, De Matteo E, Rios D, Lezama C, Galoppo M, Casciato P, Mullen E, Giadans C, Bertot G, Preciado MV, et al. Hepatic lymphocytes involved in the pathogenesis of pediatric and adult non-alcoholic fatty liver disease. Sci Rep. 2021;11(1):5129.","journal-title":"Sci Rep"},{"issue":"22","key":"3998_CR35","doi-asserted-by":"publisher","first-page":"5502","DOI":"10.3390\/cancers14225502","volume":"14","author":"M Isbell","year":"2022","unstructured":"Isbell M, Mirshahi F, Aqbi HF, Guo C, Saneshaw M, Koelsch N, Idowu MO, Austin D, Gelber C, Wang XY, et al. Restoration of CD4(+) T cells during NAFLD without modulation of the hepatic immunological pattern is not sufficient to prevent HCC. Cancers (Basel). 2022;14(22):5502.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"3998_CR36","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1002\/hep.31889","volume":"74","author":"F Barrow","year":"2021","unstructured":"Barrow F, Khan S, Wang H, Revelo XS. The emerging role of B cells in the pathogenesis of NAFLD. Hepatology. 2021;74(4):2277\u201386.","journal-title":"Hepatology"},{"issue":"1","key":"3998_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000518407","volume":"14","author":"M Nati","year":"2022","unstructured":"Nati M, Chung KJ, Chavakis T. The role of innate immune cells in nonalcoholic fatty liver disease. J Innate Immun. 2022;14(1):31\u201341.","journal-title":"J Innate Immun"},{"issue":"11","key":"3998_CR38","doi-asserted-by":"publisher","first-page":"100877","DOI":"10.1016\/j.jhepr.2023.100877","volume":"5","author":"MM Chan","year":"2023","unstructured":"Chan MM, Daemen S, Beals JW, Terekhova M, Yang BQ, Fu CF, He L, Park AC, Smith GI, Razani B, et al. Steatosis drives monocyte-derived macrophage accumulation in human metabolic dysfunction-associated fatty liver disease. JHEP Rep. 2023;5(11):100877.","journal-title":"JHEP Rep"},{"issue":"8","key":"3998_CR39","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1038\/s44321-024-00093-3","volume":"16","author":"I Hawwari","year":"2024","unstructured":"Hawwari I, Rossnagel L, Rosero N, Maasewerd S, Vasconcelos MB, Jentzsch M, Demczuk A, Teichmann LL, Meffert L, Bertheloot D, et al. Platelet transcription factors license the pro-inflammatory cytokine response of human monocytes. EMBO Mol Med. 2024;16(8):1901\u201329.","journal-title":"EMBO Mol Med"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03998-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03998-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03998-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T10:02:39Z","timestamp":1747994559000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03998-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3998"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03998-6","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The NCHS research ethics review board approved the NHANES study involving human subjects, and participants provided written informed consent upon enrollment. The studies were carried out in compliance with local regulations and institutional guidelines.Participants gave written informed consent before joining the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"399"}}